OMNIPOD DASH¿ INSULIN MANAGEMENT SYSTEM
Report
- Report Number
- 3004464228-2022-02375
- Event Type
- Malfunction
- Date Received
- February 9, 2022
- Date of Event
- February 6, 2022
- Report Date
- February 6, 2022
- Manufacturer
- INSULET CORPORATION
- Product Code
- LZG
- UDI-DI
- 20385082000020
- PMA / PMN Number
- K192659
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
THE DEVICE WAS RECEIVED FULLY DEPLOYED. INSPECTION OF THE NEEDLE MECHANISM AND CANNULA ASSEMBLY FOUND NO ISSUES THAT WOULD RESULT IN THE CANNULA INSERTING IMPROPERLY. THE CAUSE OF THE REPORTED IMPROPER INSERTION COULD NOT BE CONCLUSIVELY DETERMINED.
THE DEVICE HAS NOT BEEN RETURNED/RECEIVED TO DATE. IF THE DEVICE IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED WITH THE INVESTIGATION RESULTS. IT WAS REPORTED THE CANNULA WAS POSSIBLY NOT INSERTED CORRECTLY INTO THE INFUSION SITE. THIS CONDITION COULD INTERRUPT INSULIN DELIVERY AND CONTRIBUTE TO HYPERGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS.
H6- ADDED A150206.
IT WAS REPORTED THAT A PATIENT'S BLOOD GLUCOSE (BG) LEVELS REACHED OVER 300 MG/DL WHILE WEARING THE POD BETWEEN 4 AND 24 HOURS. DUE TO ELEVATED BG LEVELS, PATIENT LOOKED AT THE CANNULA AND WAS UNSURE IF THE CANNULA WAS PROPERLY SEATED IN THE INFUSION SITE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 945618 | OMNIPOD DASH¿ INSULIN MANAGEMENT SYSTEM | PUMP, INFUSION, INSULIN | LZG | INSULET CORPORATION | 18320 | PD1C06092151 | 20385082000020 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 20 YR | Female |